Oncolytics Biotech Inc T.ONC

PanCan Adaptive Clinical Trial Design

[askretka]

Good info here. Video too if you scroll down. 

https://www.curetoday.com/view/adaptive-clinical-trial-design-aims-to-accelerate-research-and-approvals-in-pancreatic-cancer

-------------------------------
Cheers!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

[Noteable]

The Precision Promise adaptive trial is designed around the model of "continuous improvement" that imvolves the continuous improvment of treatment options - where novel treatments are compared to the standard of care (SOC) at the time - and the SOC changing over time once a more effective treatment is discovered and adopted as the new SOC.

[Noteable]

Quote: "And then another thing that's really neat about the control arm and Precision Promise is that it's something that becomes permanent. It becomes its own story: what's the standard of care for pancreas cancer? As time goes on, the control arm changes because we do change how we do things. And that and that control arm will adapt as well. So, in that sense, the trial is very,

[Noteable]

Interesting PanCan news feed: https://www.curetoday.com/advocacy-groups/pancan Also: June 23, 2023 - The Food and Drug Administration (FDA) accepted a supplemental new drug application for Onivyde (irinotecan liposome injection) plus 5-fluorouracil/leucovorin and oxaliplatin (NALIRIFOX regimen) as a potential first-line treatment for patients with metastatic pancreatic ductal adenocarcinoma